Head of Transactions, Business Development & Licensing, BioPharmaceuticals R&D, AstraZeneca
Bavani Shankar has more than 20 years of experience in business development in the pharmaceutical, biotechnology and specialty pharmaceutical companies.
Bavani joined AstraZeneca in 2012 and assumed the role of head of business development for Neuroscience; during this time, she led deal teams to execute strategic co-development, co-commercialization deals in Neuroscience.
As of November 2019, Bavani has assumed a new role as Head of Transaction, Business Development & Licensing, BioPharmaceuticals R&D and is responsible for all transactions upto and including Phase-2 for the Early Respiratory, Inflammation & Autoimmunity (RIA), Early Cardiovascular, Renal & Metabolic (CVRM) and Neuroscience therapy areas.
Prior to joining AstraZeneca, Bavani was Vice President Corporate Development at PsychoGenics Inc. and was instrumental in executing and managing multiple collaborations with major pharmaceutical companies.
Bavani has a B.S. in Engineering and an MBA with concentration in management and finance from Columbia Universty.